Beta Bionics logo

Beta Bionics, Inc.


Beta Bionics Stock

Beta Bionics is a biotechnology company that specializes in innovative diabetes management solutions, particularly focusing on type 1 diabetes. The company is known for its development of the iLet Bionic Pancreas, a device that automates insulin delivery.

Founded: 2015

Beta Bionics Website

Beta Bionics Company Overview


Management Team

Sean Saint CEO
Steven Russell Chief Medical Officer
Mike Mensinger CPO
Stephen Feider CFO

Funding Information